Table 2. JMJD5 expression in different clinicopathological characteristics groups.
| Characteristics | JMJD5 | P value | |
|---|---|---|---|
| Low, n (%) | High, n (%) | ||
| Age (y) | 0.872 | ||
| <60 | 31 (72.1) | 12 (27.9) | |
| ≥60 | 28 (73.7) | 10 (26.3) | |
| Gender | 0.299 | ||
| Male | 49 (75.4) | 16 (24.6) | |
| Female | 10 (62.5) | 6 (37.5) | |
| Histopathology | 0.356 | ||
| Adenocarcinoma | 24 (66.7) | 12 (33.3) | |
| Squama | 34 (79.1) | 9 (20.9) | |
| Othersa | 1 (50.0) | 1 (50.0) | |
| Lymph node metastasis | 0.103 | ||
| No | 25 (83.3) | 5 (16.7) | |
| Yes | 34 (66.7) | 17 (33.3) | |
| TNM stage | 0.075 | ||
| I–II | 42 (79.2) | 11 (20.8) | |
| III–IV | 17 (60.7) | 11 (39.3) | |
| Differentiation | 0.371 | ||
| Poor | 31 (68.9) | 14 (31.1) | |
| Good-moderate | 28 (77.8) | 8 (22.2) | |
| Smoking history | 0.364 | ||
| No | 13 (65.0) | 7 (35.0) | |
| Yes | 46 (75.4) | 15 (24.6) | |
a, others including adenosquamous carcinoma, large cell carcinoma, sarcoma, etc. Data were analyzed by chi-square test. JMJD5, Jumonji domain containing 5.